Novel approach to specific growth factor inhibition in vivo: Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 169-179

  Floege, Jürgen ^a   Ostendorf, Tammo ^a   Janssen, Ulf ^a   Burg, Michael ^a   Radeke, Heinfried H ^a   Vargeese, Chandra ^b   Gill, Stanley C ^b   Green, Louis S ^b   Janjić, Nebojša ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GROWTH FACTOR; MACROGOL; MESSENGER RNA; OLIGONUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR B APTAMER; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BETA CHAIN; CELL CULTURE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESANGIUM CELL; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032896149     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65263-7     Document Type: Article

References (36)

1. Tuerk C, Gold L: Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510
2. Ellington A, Szostak J: In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822
3. Ross R: Cell biology of atherosclerosis. Annu Rev Physiol 1995, 57:791-804
4. Floege J, Johnson RJ: Multiple roles for platelet-derived growth factor in renal disease. Miner Electrolyte Metab 1995, 21:271-282
5. Slomowitz LA, Klahr S, Schreiner GF, Ichikawa I: Progression of renal disease. N Engl J Med 1988, 319:1547-1548
6. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992, 175:1413-1416
7. Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl 1993, 39:S47-S54
8. Green LS, Jellinek D, Jenison R, Östman A, Heldin CH, Janjić N: Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 1996, 35:14413-14424
9. Willis MC, Collins BD, Zhang T, Green LS, Sebesta D, Bell C, Kellogg E, Gill SC, Magillanez A, Knauer S, Bendele RA, Gill PS, Janjić N: Liposome-anchored vascular endothelial growth factor aptamers. Bioconj Chem 1998, 9:573-582
10. Radeke HH, Gessner JE, Uciechowski P, Magert HJ, Schmidt RE, Resch K: Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFcγRIII-A) and the associated Fc∈RI γ-chain. J Immunol 1994, 153:1281-1292
11. Floege J, Topley N, Hoppe J, Barrett TB, Resch K: Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol 1991, 86:334-341
12. Lonnemann G, Shapiro L, Engler Blum G, Muller GA, Koch KM, Dinarello CA: Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int 1995, 45:837-844
13. Johnson RJ, Garcia RL, Pritzl P, Alpers CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 1990, 136:369-374
14. Burg M, Ostendorf T, Mooney A, Koch KM, Floege J: Treatment of experimental mesangioproliferative glomerulonephritis with non-anti-coagulant heparin: therapeutic efficacy and safety. Lab Invest 1997. 76:505-516
15. Yoshimura A, Gordon K, Alpers CE, Floege J, Pritzl P, Ross R, Couser WG, Bowen-Pope DF, Johnson RJ: Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int 1991, 40:470-476
16. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996, 49:666-678
17. Hugo C, Pichler R, Gordon K, Schmidt R, Amieva M, Couser WG, Furthmayr H, Johnson RJ: The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J Clin Invest 1996, 97:2499-2508
18. Eitner F, Westerhuis R, Burg M, Weinhold B, Gröne HJ, Ostendorf T, Rüther U, Koch KM, Rees AJ, Floege J: Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int 1997, 51:69-78
19. Pieken WA., Olsen DB, Benseler F, Aurup H, Eckstein F: Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science 1991, 253:314-317
20. Cummins LL, Owens SR, Risen LM, Lesnik EA, Freier SM, McGee D, Guinosso CJ, Cook PD: Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res 1995, 23:2019-2024
21. Herren B, Weyer KA, Rouge M, Lötscher P, Pech M: Conservation in sequence and affinity of human and rodent PDGF ligands and receptors. Biochim Biophys Acta 1993, 1173:294-302
22. Lindner V, Giachelli CM, Schwartz SM, Reidy MA: A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor B-chain. Circ Res 1995, 76:951-957
23. Gold L, Polisky B, Uhlenbeck OC, Yarus M: Diversity of oligonucleotide functions. Annu Rev Biochem 1995, 64:763-797
24. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991, 87:847-858
25. Canaan-Kühl S, Ostendorf T, Zander K, Koch KM, Floege J: C-natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int 1998, 53:1143-1151
26. Yamamoto T, Wilson CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 1987, 32:514-525
27. Hugo C, Shankland SJ, Bowen-Pope DF, Couser WG, Johnson RJ: Extraglomerular origin of the mesangial cell after injury. J Clin Invest 1997, 100:786-794
28. Fujinaka H, Yamamoto T, Takeya M, Feng L, Kawasaki K, Yaoita E, Kondo D, Wilson CB, Uchiyama M, Kihara I: Suppression of antiglomerular basement membrane nephritis by administration of antimonocyte chemoattractant protein-1 antibody in WKY rats. J Am Soc Nephrol 1997, 8:1174-1178
29. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 1990, 346:371-374
30. Goppelt-Struebe M, Stroebel M: Synergistic induction of monocyte chemoattractant protein-1 by platelet-derived growth factor and interleukin-1. FEBS Lett 1995, 374:375-378
31. Nangaku M, Pippin J, Richardson CA, Schulze M, Young BA, Alpers CE, Gordon KL, Johnson RJ, Couser WG: Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy. Kidney Int 1996, 50:2054-2062
32. Gesualdo L, DiPaolo S, Ranieri E, Schena FP: Trapidil inhibits human mesangial cells proliferation: effect on PDGF β-receptor binding and expression. Kidney Int 1994, 46:1002-1009
33. Yagi M, Kato S, Kobayashi Y, Kobayashi N, Iinuma N, Nagano N, Yamamoto T: Beneficial effects of a selective platelet-derived growth factor receptor autophosphorylation inhibitor on proliferative glomerulonephritis in the rats. J Am Soc Nephrol 1997, 8:488A
34. Griffin LC, Tidmarsh GF, Bock LC, Toole JJ, Leung LLK: In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 1993, 81:3271-3276
35. Hicke BJ, Watson SR, Koenig A, Lynott CK, Bargatze RF, Chang YF, Ringquist S, Moon-McDermott L, Jennings S, Fitzwater T, Han HL, Varki N, Albinana I, Willis MC, Varki A, Parma D: DNA aptamers block L-setectin function in vivo. J Clin Invest 1996, 98:2688-2692
36. Bless NM, Smith D, Charlton J, Czermak BJ, Schmal H, Friedl HP, Ward PA: Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury. Curr Biol 1997, 7:877-880